Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mullen

Showing results (451-460 of 492) with videos related to

Pageof 50
Sort By:
Pediatric Blood & Cancer|May 14, 2025
Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology PerspectivesKathryn S Sutton, Amy L Walz, Alissa Groenendijk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2019
Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study ReportDavid B Dix, Conrad V Fernandez, Yueh-Yun Chi, et al.
Annals of Surgical Oncology|January 24, 2022
Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis: A Report from the Children's Oncology Group Study AREN0534Peter F Ehrlich, Brett Tornwall, Murali M Chintagumpala, et al.
Annals of Surgery|November 5, 2016
Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532Conrad V Fernandez, Elizabeth J Perlman, Elizabeth A Mullen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2020
Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 StudyNajat C Daw, Yueh-Yun Chi, John A Kalapurakal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2025
Impact of Pulmonary Tumor Burden in Favorable Histology Wilms Tumor Outcomes: A Report From the Children's Oncology Group Study AREN0533David B Dix, Geetika Khanna, Lindsay A Renfro, et al.
Journal of the American College of Surgeons|January 22, 2024
Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2Harold N Lovvorn, Lindsay A Renfro, Daniel J Benedetti, et al.
Cancer|May 28, 2020
Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology GroupPeter F Ehrlich, Yueh-Yun Chi, Murali M Chintagumpala, et al.
Annals of Surgery|August 11, 2017
Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology GroupPeter Ehrlich, Yuen Y Chi, Murali M Chintagumpala, et al.
Biomedicines|May 27, 2026
Integrated Molecular, Genomic, and Clinical Characterization of Pediatric and Adolescent Translocation Renal Cell Carcinoma: A Report from the Children's Oncology GroupAlissa Groenendijk, Bruce J Aronow, Nicholas Cost, et al.
Pageof 50

Showing results (451-460 of 492) with videos related to

Sort By:
Pageof 50
Pediatric Blood & Cancer|May 14, 2025
Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology PerspectivesKathryn S Sutton, Amy L Walz, Alissa Groenendijk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2019
Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study ReportDavid B Dix, Conrad V Fernandez, Yueh-Yun Chi, et al.
Annals of Surgical Oncology|January 24, 2022
Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis: A Report from the Children's Oncology Group Study AREN0534Peter F Ehrlich, Brett Tornwall, Murali M Chintagumpala, et al.
Annals of Surgery|November 5, 2016
Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532Conrad V Fernandez, Elizabeth J Perlman, Elizabeth A Mullen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2020
Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 StudyNajat C Daw, Yueh-Yun Chi, John A Kalapurakal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2025
Impact of Pulmonary Tumor Burden in Favorable Histology Wilms Tumor Outcomes: A Report From the Children's Oncology Group Study AREN0533David B Dix, Geetika Khanna, Lindsay A Renfro, et al.
Journal of the American College of Surgeons|January 22, 2024
Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2Harold N Lovvorn, Lindsay A Renfro, Daniel J Benedetti, et al.
Cancer|May 28, 2020
Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology GroupPeter F Ehrlich, Yueh-Yun Chi, Murali M Chintagumpala, et al.
Annals of Surgery|August 11, 2017
Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology GroupPeter Ehrlich, Yuen Y Chi, Murali M Chintagumpala, et al.
Biomedicines|May 27, 2026
Integrated Molecular, Genomic, and Clinical Characterization of Pediatric and Adolescent Translocation Renal Cell Carcinoma: A Report from the Children's Oncology GroupAlissa Groenendijk, Bruce J Aronow, Nicholas Cost, et al.
Pageof 50